COST-EFFECTIVENESS ANALYSIS OF NIRMATRELVIR/RITONAVIR COMPARED WITH MOLNUPIRAVIR IN PATIENTS AT HIGH RISK FOR PROGRESSION TO SEVERE COVID-19 IN JAPAN

被引：0
|
作者：
Yuasa, A. [1 ]
Matsuda, H. [2 ]
Fujii, Y. [3 ]
Kado, Y. [2 ]
Murata, K. [1 ]
Yoshida, M. [3 ]
Mugwagwa, T. [4 ]
Gu, Y. [5 ]
机构：
[1] Pfizer Japan Inc, Shibuya Ku, Tokyo, Japan
[2] IQVIA Solut Japan GK, Minato Ku, Tokyo, Japan
[3] Pfizer R&D Japan GK, Shibuya Ku, Tokyo, Japan
[4] Pfizer Inc, New York, NY USA
[5] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo, Japan
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE180
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [31] In patients with COVID-19 at risk for severe disease, nirmatrelvir plus ritonavir reduced hospitalization or death
    Vassilopoulos, Athanasios
    Mylonakis, Eleftherios
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (06) : JC63 - JC63
  • [32] Efficacy and Safety of Nirmatrelvir/Ritonavir in Severe Hospitalized Patients with COVID-19 and in Patients at High Risk for Progression to Critical Illness: A Real-World Study
    Chen, Xiaohua
    Zhu, Ying
    Shen, Leer
    Zhou, Dan
    Feng, Nannan
    Tong, Qiang
    JOURNAL OF INTENSIVE CARE MEDICINE, 2024, 39 (08) : 742 - 750
  • [33] Additional analyses support superior efficacy of nirmatrelvir/ritonavir over molnupiravir for COVID-19
    Chang, Li-Chen
    Chen, I-Wen
    Hung, Kuo-Chuan
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (02)
  • [34] Comparative efficacy and safety of nirmatrelvir/ritonavir and molnupiravir for COVID-19: A systematic review and meta-analysis
    Amani, Bahman
    Akbarzadeh, Arash
    Amani, Behnam
    Shabestan, Rouhollah
    Khorramnia, Saeed
    Navidi, Zia
    Rajabkhah, Kourosh
    Kardanmoghadam, Vida
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (06)
  • [35] Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients
    Kim, Min-Kyung
    Lee, Kyung-Shin
    Ham, Sin Young
    Choi, Youn Young
    Lee, Eunyoung
    Lee, Seungjae
    Lee, Bora
    Jeon, Jaehyun
    Chin, Bumsik
    Kim, Yeonjae
    Kim, Gayeon
    Jang, Hee -Chang
    Choi, Jae-Phil
    Park, Sang -Won
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (35)
  • [36] Clinical Effectiveness of Nirmatrelvir plus Ritonavir in the Treatment of COVID-19 for Patients With Dementia
    Liu, Ting-Hui
    Hsu, Wan-Hsuan
    Tsai, Ya-Wen
    Wu, Jheng-Yan
    Chuang, Min-Hsiang
    Lai, Chih-Cheng
    Huang, Po-Yu
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2023, 24 (08) : 1159 - 1162
  • [37] Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis
    Hsu, Wan-Hsuan
    Shiau, Bo-Wen
    Liu, Ting-Hui
    Wu, Jheng-Yan
    Tsai, Ya-Wen
    Huang, Po-Yu
    Chuang, Min-Hsiang
    Lai, Chih-Cheng
    Chen, Chi-Hsing
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (10) : 1143 - 1151
  • [38] Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19
    Kauer, Victoria
    Totschnig, David
    Waldenberger, Ferdinand
    Augustin, Max
    Karolyi, Mario
    Naegeli, Michelle
    Wenisch, Christoph
    Zoufaly, Alexander
    VIRUSES-BASEL, 2023, 15 (05):
  • [39] Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience
    Tiseo, Giusy
    Barbieri, Chiara
    Galfo, Valentina
    Occhineri, Sara
    Matucci, Tommaso
    Almerigogna, Francesco
    Kalo, Jona
    Sponga, Pietro
    Cesaretti, Mario
    Marchetti, Gabriele
    Forniti, Arianna
    Caroselli, Claudio
    Ferranti, Simone
    Pogliaghi, Manuela
    Polidori, Marina
    Fabiani, Silvia
    Verdenelli, Stefano
    Tagliaferri, Enrico
    Riccardi, Niccolo
    Suardi, Lorenzo Roberto
    Carmignani, Claudia
    Batini, Serena
    Puccetti, Luca
    Iapoce, Riccardo
    Menichetti, Francesco
    Falcone, Marco
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (01) : 257 - 271
  • [40] Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non- hospitalised and hospitalised patients with COVID-19: a target trial emulation study
    Wan, Eric Yuk Fai
    Yan, Vincent Ka Chun
    Wong, Zoey Cho Ting
    Chui, Celine Sze Ling
    Lai, Francisco Tsz Tsun
    Li, Xue
    Wong, Carlos King Ho
    Hung, Ivan Fan Ngai
    Lau, Chak Sing
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    ECLINICALMEDICINE, 2023, 64
12345